Truxima (Rituximab-abbs)
TRUXIMA (rituximab-abbs) is a CD20-directed cytolytic antibody indicated for the treatment of adult patients with: Non-Hodgkin’s Lymphoma (NHL) (1.1). Relapsed or refractory, low grade or…
TRUXIMA (rituximab-abbs) is a CD20-directed cytolytic antibody indicated for the treatment of adult patients with: Non-Hodgkin’s Lymphoma (NHL) (1.1). Relapsed or refractory, low grade or…
RIABNI is a CD20-directed cytolytic antibody indicated for the treatment of: Adult patients with non-Hodgkin’s Lymphoma (NHL) (1.1). Relapsed or refractory, low grade or follicular…
RUXIENCE is a CD20-directed cytolytic antibody indicated for the treatment of: Adult patients with Non-Hodgkin’s Lymphoma (NHL) (1.1). o Relapsed or refractory, low grade or…
XARELTO is a factor Xa inhibitor indicated: to reduce risk of stroke and systemic embolism in nonvalvular atrial fibrillation (1.1) for treatment of deep vein thrombosis (DVT) (1.2) for…
XARELTO is a factor Xa inhibitor indicated: to reduce risk of stroke and systemic embolism in nonvalvular atrial fibrillation (1.1) for treatment of deep vein thrombosis (DVT) (1…
This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.
Privacy Policy | Copyright © 2024. All Rights Reserved.